Bernard Lerer

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 15

Top Topics

Machine Learning

Deep Brain Stimulation

Prefrontal Cortex

Top Venues

Translational psychiatry

Molecular psychiatry

bioRxiv : the preprint server for biology

This page only lists publications with an associated author ORCID identifier.

Publications

Michal Brownstien, Michal Lazar, Alexander Botvinnik, Chloe Shevakh, Karin Blakolmer, Leonard Lerer, Tzuri Lifschytz, Bernard Lerer
Striking Long Term Beneficial Effects of Single Dose Psilocybin and Psychedelic Mushroom Extract in the SAPAP3 Rodent Model of OCD-Like Excessive Self-Grooming. bioRxiv : the preprint server for biology (2024)
Orr Shahar, Alexander Botvinnik, Amit Shwartz, Elad Lerer, Peretz Golding, Alex Buko, Ethan Hamid, Dani Kahn, Miles Guralnick, Karin Blakolmer, Gilly Wolf, Amit Lotan, Leonard Lerer, Bernard Lerer, Tzuri Lifschytz
Effect of chemically synthesized psilocybin and psychedelic mushroom extract on molecular and metabolic profiles in mouse brain. Molecular psychiatry (2024)
Michal Brownstien, Michal Lazar, Alexander Botvinnik, Chloe Shevakh, Karin Blakolmer, Leonard Lerer, Tzuri Lifschytz, Bernard Lerer
Striking Long Term Beneficial Effects of Single Dose Psilocybin and Psychedelic Mushroom Extract in the SAPAP3 Rodent Model of OCD-Like Excessive Self-Grooming. bioRxiv : the preprint server for biology (2024)
Uriel Heresco-Levy, Bernard Lerer
Synergistic psychedelic - NMDAR modulator treatment for neuropsychiatric disorders. Molecular psychiatry (2023)
Dotan Moskovich, Yael Finkelshtein, Adi Alfandari, Amit Rosemarin, Tzuri Lifschytz, Avivit Weisz, Santanu Mondal, Harinarayana Ungati, Aviva Katzav, Debora Kidron, Govindasamy Mugesh, Martin Ellis, Bernard Lerer, Osnat Ashur-Fabian
Correction: Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatment. Oncogene (2023)
Sandeep Singh, Alexander Botvinnik, Orr Shahar, Gilly Wolf, Corel Yakobi, Michal Saban, Adham Salama, Amit Lotan, Bernard Lerer, Tzuri Lifschytz
Effect of psilocybin on marble burying in ICR mice: role of 5-HT1A receptors and implications for the treatment of obsessive-compulsive disorder. Translational psychiatry 13 (1) (2023)
Sandeep Singh, Alexander Botvinnik, Orr Shahar, Gilly Wolf, Corel Yakobi, Michal Saban, Adham Salama, Amit Lotan, Bernard Lerer, Tzuri Lifschytz
Effect of psilocybin on marble burying in ICR mice: role of 5-HT1A receptors and implications for the treatment of obsessive-compulsive disorder. Translational psychiatry 13 (1) (2023)
Sandeep Singh, Alexander Botvinnik, Orr Shahar, Gilly Wolf, Corel Yakobi, Michal Saban, Adham Salama, Amit Lotan, Bernard Lerer, Tzuri Lifschytz
Effect of psilocybin on marble burying in ICR mice: role of 5-HT1A receptors and implications for the treatment of obsessive-compulsive disorder. Translational psychiatry 13 (1) (2023)
Sandeep Singh, Alexander Botvinnik, Orr Shahar, Gilly Wolf, Corel Yakobi, Michal Saban, Adham Salama, Amit Lotan, Bernard Lerer, Tzuri Lifschytz
Effect of psilocybin on marble burying in ICR mice: role of 5-HT1A receptors and implications for the treatment of obsessive-compulsive disorder. Translational psychiatry 13 (1) (2023)
Sandeep Singh, Alexander Botvinnik, Orr Shahar, Gilly Wolf, Corel Yakobi, Michal Saban, Adham Salama, Amit Lotan, Bernard Lerer, Tzuri Lifschytz
Effect of psilocybin on marble burying in ICR mice: role of 5-HT1A receptors and implications for the treatment of obsessive-compulsive disorder. Translational psychiatry 13 (1) (2023)
Orr Shahar, Alexander Botvinnik, Noam Esh-Zuntz, Michal Brownstien, Rachel Wolf, Amit Lotan, Gilly Wolf, Bernard Lerer, Tzuri Lifschytz
Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 Receptors in the Head Twitch Response Induced by 5-Hydroxytryptophan and Psilocybin: Translational Implications. International journal of molecular sciences 23 (22) (2022)
Gilly Wolf, Sandeep Singh, Karin Blakolmer, Leonard Lerer, Tzuri Lifschytz, Uriel Heresco-Levy, Amit Lotan, Bernard Lerer
Could psychedelic drugs have a role in the treatment of schizophrenia? Rationale and strategy for safe implementation. Molecular psychiatry (2022)
Dotan Moskovich, Yael Finkelshtein, Adi Alfandari, Amit Rosemarin, Tzuri Lifschytz, Avivit Weisz, Santanu Mondal, Harinarayana Ungati, Aviva Katzav, Debora Kidron, Govindasamy Mugesh, Martin Ellis, Bernard Lerer, Osnat Ashur-Fabian
Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatment. Oncogene 40 (44) (2021)
Dekel Taliaz, Amit Spinrad, Ran Barzilay, Zohar Barnett-Itzhaki, Dana Averbuch, Omri Teltsh, Roy Schurr, Sne Darki-Morag, Bernard Lerer
Optimizing prediction of response to antidepressant medications using machine learning and integrated genetic, clinical, and demographic data. Translational psychiatry 11 (1) (2021)
Anna Alkelai, Lior Greenbaum, Anna R Docherty, Andrey A Shabalin, Gundula Povysil, Ayan Malakar, Daniel Hughes, Shannon L Delaney, Emma P Peabody, James McNamara, Sahar Gelfman, Evan H Baugh, Anthony W Zoghbi, Matthew B Harms, Hann-Shyan Hwang, Anat Grossman-Jonish, Vimla Aggarwal, Erin L Heinzen, Vaidehi Jobanputra, Ann E Pulver, Bernard Lerer, David B Goldstein
The benefit of diagnostic whole genome sequencing in schizophrenia and other psychotic disorders. Molecular psychiatry (2021)